Germany-Results from a phase 3 trial of infliximab (Remicade, Centocor & Schering-Pough) in moderate to severe psoriasis show that monotherapy is "highly effective in the treatment of skin and ...

SAN ANTONIO, TX, February 1, 2008 -- Data from an integrated analysis of three randomized, placebo-controlled trials showed patients with moderate to severe plaque psoriasis receiving REMICADE ...

In a separate analysis from the Evaluation of Infliximab for Psoriasis in a [REMICADE] Efficacy and Safety Study (EXPRESS II), among patients with severe psoriasis who were either dissatisfied ...

In certain types of arthritis, gut conditions, and plaque psoriasis, you may have higher-than-normal TNF levels. Infliximab works by blocking some forms of TNF. By blocking TNF, infliximab may ...

Back to Healio Patients with psoriasis being treated with Remicade had no significant change in clinical response and experienced minor adverse events when switching to an infliximab biosimilar ...

An integrated analysis of data from three pivotal trials shows that patients with severe psoriasis experienced significant improvements with Remicade therapy An integrated analysis of data from ...

Psoriasis independently linked to diabetes risk 'Real-world' study data mirror that of earlier phase 3 trials. Infliximab is safe and effective for treating psoriasis, results from phase 4 study ...

A retrospective analysis of US medical records of people aged 65-95 years finds those with psoriasis on systemic therapies ...

4.1 The Appraisal Committee reviewed the data available on the clinical and cost effectiveness of infliximab for the treatment of adults with psoriasis, having considered evidence on the nature of the ...

UAB is expanding services for patients who seek relief from the itching, cracking and bleeding skin caused by psoriasis. Long-suffering patients are heralding the drug infliximab (Remicade), given as ...

You may use drugs such as adalimumab (Humira Pen, Humira Pen Crohn's-UC-HS Start, Humira Pen Psoriasis-Uveitis), etanercept (Enbrel), or infliximab (Avsola, Inflectra, Ixifi, Remicade, Renflexis).